US 10172911
Methods of modulating erythropoiesis with arginine vasopressin receptor 1B molecules
granted A61KA61K31/404A61K31/465
Quick answer
US patent 10172911 (Methods of modulating erythropoiesis with arginine vasopressin receptor 1B molecules) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jan 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K31/404, A61K31/465, A61K38/095, A61K38/1816